Beam Therapeutics Inc.
CEO
John Evans
IPO Date
2020-02-06
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Beam Therapeutics Inc. (BEAM) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
Beam Therapeutics to Participate in the 2021 Wedbush PacGrow Healthcare Conference
Beam Therapeutics to Participate in the 2021 William Blair Biotech Focus Conference
Why Beam Therapeutics Jumped Today
Beam Therapeutics to Participate in the 2021 Jefferies Virtual Healthcare Conference
Beam Therapeutics Takes $155M In-Process R&D Expense Hit To Bottomline, But Receives Buy Rating From Redburn Partners
Beam Therapeutics Inc. (BEAM) Reports Q1 Loss, Lags Revenue Estimates